Sanofi SA reported sales of €8.8 billion in the first quarter, up by 12.3% from a year earlier on strong sales of veterinary drugs and medicines from the company’s Genzyme unit. Diabetes product sales however fell by 3.2% on a decline in sales for Lantus.
